Timothy Franson

Insider profile

Currently holds positions in Cidara Therapeutics Inc and Paratek Pharmaceuticals Inc

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -13% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Cidara Therapeutics Inc March 1, 2015 -
Independent Director Paratek Pharmaceuticals Inc July 21, 2015 -
Timothy Franson's trades of Paratek Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
330.51
Quantity 161 +35.7%
Value US$3,783,432
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-02-23 2023-02-21
PlS Planned sale
2,108 -21.5%
267.84
US$2,938,827 		2,108 -21.5% 267.84 US$2,938,827
2021-09-14 2021-09-13
B Purchase
161 +35.7%
330.51
US$3,783,432 		161 +35.7% 330.51 US$3,783,432